270 likes | 375 Views
Epidemiology. HSTAT1101: 27. oktober 2004 Odd Aalen. Measuring disease occurrence. The aim of epidemiology is to map disease occurrence statistically, so that the disease may be better understood and perhaps prevented This requires measures of disease occurrence. Two major measures:
E N D
Epidemiology HSTAT1101: 27. oktober 2004 Odd Aalen
Measuring disease occurrence • The aim of epidemiology is to map disease occurrence statistically, so that the disease may be better understood and perhaps prevented • This requires measures of disease occurrence. Two major measures: • prevalence • incidence rate
Types of study • Cross-sectional study • assessing the situation at one specific time (example: how many smokers and non-smokers have asthma at the present time) • Cohort (or follow-up) study • looking ahead in time (e.g. follow-up of smokers and non-smokers to observe occurrence of asthma) • Case-control study • looking back in time (e.g.: patients with asthma are compared with control group to look for previous risk factors, e.g. smoking)
Epidemiology 2004;15: 653–659 Lönn et al
Prevalence • Prevalence: The proportion of a population that has a certain condition at a specified time • Example: • Prevalence of asthma in Norway: 2.4% • Prevalence of multiple sclerosis in Norway: 100 per 100,000 (Note: Sometimes another basis number than 100,000 may be used, e.g. 1 million)
Estimating prevalence • Need an estimate of the population size • Need an estimate of the number of cases of disease. Cross-sectional design is sufficient • Requires definition of case. This is often not obvious: • example: asthma (dyspnea, wheezing, cough, spirometric measurements) • sometimes an apparent increase in prevalence is due to a changing definition (or increased awareness) of disease
Incidence rate • Incidence: Rate of new cases per year of a certain condition: • Examples: • Incidence of multiple sclerosis in Norway: 5 per 100,000 person years • Incidence of HIV infection in Oslo in 2000: 11 per 100,000 person years
Estimating incidence • Need an estimate of the population size or “person-years” • Need an estimate of the number of new cases of disease over some time period (e.g. one year) • requires definition of when the disease started (e.g. time of first diagnosis by a medical doctor) • Preferably a cohort (follow-up) study
Prevalence vs. Incidence • Incidence measures risk of disease • Prevalence measures burden of disease • The burden may increase because the risk increases, or because the disease lasts longer, e.g. if mortality of disease decreases
Illustration of basic concepts Incidence Prevalence Recovery Death
Example:HIV-infection • With new treatments progression to AIDS or death has been strongly decreased • No complete recovery takes place • The incidence of HIV infection is largely unchanged • This results in considerably increased prevalence of HIV infection
Computing an incidence rate by the person-years method • The incidence rate is estimated as • By person-years we mean the sum of the observation times for all individuals
Example • From the Cancer Registry of Norway: • During 1983-87 there were 460 cases of breast cancer among women in the age group 30-39 years • The population in this age group in 1985 was 302,501. Number of person-years are 302,501 × 5 • The incidence rate is:
Example • On the next slide is presented incidence of malignant melanoma in Norway, a disease which has become much more common over the last few decades • The incidence is age-adjusted, to correct for changing age-composition. This is done by standardization
Incidence of malignant melanoma among women in Norway 1956-1995
Population and sample • The population consist of all the individuals we want to study. Examples: • All people between 20 and 60 years of age in a city • All people in the country suffering from tuberculosis • People in a profession: e.g. bus drivers • The sample consist of those individuals that are actually included in the study
Sampling Total population Random sampling Study population
Association and causation • Epidemiology gives us statistical associations • Example: smokers have much higher risk of lung cancers than non-smokers • Example: People with high blood pressure have increased risk of heart disease • Association does not necessarily imply that the factor is a biological cause
Confounding • Example: Cigarette smoking in mothers is associated with sudden infant death (SIDS). Is this causal? • Smoking could be an indicator of other lifestyle factors that influence the risk of SIDS. • Such “other factors” that could explain an association are called confounders
Survival analysis • Studying durations: • duration of disease • duration of remission • duration of marriage • age at breast cancer diagnosis • Durations are important clinical and epidemiological outcome parameters • do patients live longer • does the remission period last longer • can we postpone disease
Censoring • Special problem of duration data: incompletely observed times (censored data). Causes: • study is terminated • withdrawal • observation ceases • Basic assumption: No selective censoring • the individuals which get censored at any given time shall not differ, on the average, from those that are under observation but not censored at that time • can be modified for Cox-regression • Censoring precludes the use of ordinary statistical methods for measurement data
Small example • Data set 26, 17, 7*, 41, 34*, 9, 13, 25*, 37, 18 * censoring time • The same data ordered: 7*, 9, 13, 17, 18, 25*, 26, 34*, 37, 41
Graphical presentation • Survival curve: Describing proportion that survives up to some time • Hazard rate: Describing risk of event (death, relapse etc) as function of time
Treatment of acute myocardial infarction • Analyzed by Cox model, adjusted hazard ratio 2.31 • Propor-tionality?